Company attributes
B2X
Pitchbook URL
Legal Name
Galapagos NV
Date Incorporated
1999
Number of Employees (Ranges)
1,001 – 5,000
Email Address
ir@glpg.com
Phone Number
+32153429000
+331494246460
+317175067000
Full Address
Aeschengraben 20 4051 Basel Switzerland0
Regus Building Mendelweg 32 2333 CS Leiden, the Netherlands0
102 Avenue Gaston Roussel 93230 Romainville, France0
Generaal De Wittelaan L11 A3 2800 Mechelen Belgium0
230 CityPoint 230 Third Avenue Waltham, MA 02451 USA0
CIK Number
Investors
Founded Date
2000
0Fax Number
+32 15 34 29 01
Total Funding Amount (USD)
5,421,331,296
Latest Funding Round Date
July 2019
Stock Symbol
GLPG0
Exchange
Board of Directors
CFO
Latest Funding Type
Patents Assigned (Count)
65
Country
Headquarters
Other attributes
Company Operating Status
Active
Directed by (Film)
Latest Funding Round Amount (USD)
5,100,000,000
Ticker Symbol
GLPG
Wikidata ID
Founded in 1999, Galapagos NV is a clinical-stage biotech firm that develops and commercializes small molecule medicines. Their pipeline consists of several studies, and preclinical programs in cystic fibrosis, osteoarthritis, inflammation, and other indications.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
